Biomarker-Based CardioMEMS Candidates Benefit Less : vimarsa

GUIDE-HF trial analysis distinguishes risk 'strata' with different levels of benefit

Related Keywords

United States , Boston , Massachusetts , America , Mandeepr Mehra , Barryh Greenberg , , Harvard Medical School , University Of California San Diego , Heart Failure Society Of America , York Heart Association , New York Heart Association , Heart Failure Society , California San , Kansas City Cardiomyopathy Questionnaire , Failure Society , Hemodynamic Guided Management , Heart Failure ,